Form 4 for VCEL Vericel Corp
Accepted 2025-03-14 00:00:00 ET · period of report 2025-03-12 · accession 0001140361-25-008820 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-03-14 | 2025-03-12+ | VCEL | Colangelo Dominick | Pres, CEO, Dir | M - OptEx | $1.95 | +53.2K | 286.6K | +23% | +$103.7K |
| DMT | 2025-03-14 | 2025-03-12+ | VCEL | Colangelo Dominick | Pres, CEO, Dir | S - Sale+OE | $46.04 | -53.2K | 260.0K | -17% | -$2.45M |
| DMT | 2025-03-14 | 2025-03-12+ | VCEL | Colangelo Dominick | Pres, CEO, Dir | M - OptEx | $0.00 | +53.2K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-13 | M | A | 26,592 | $1.95 | 286,589 | D | — | — | (F1) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 2 | Common | Common Stock | 2025-03-12 | S | D | 26,591 | $46.31 | 259,997 | D | — | — | (F2) The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2024. (F1) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 3 | Common | Common Stock | 2025-03-12 | M | A | 26,591 | $1.95 | 286,588 | D | — | — | (F1) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 4 | Common | Common Stock | 2025-03-13 | S | D | 26,592 | $45.78 | 259,997 | D | — | — | (F2) The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2024. (F1) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-03-12 | M | A | 26,591 | $0.00 | 26,592 | D | $1.95 · — to — | 26,591 Common Stock | (F3) These options, representing the right to purchase 165,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted. (F4) These options, which were awarded on February 9, 2016, would otherwise expire and become forfeitable on February 9, 2026. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-03-13 | M | A | 26,592 | $0.00 | 0 | D | $1.95 · — to — | 26,592 Common Stock | (F3) These options, representing the right to purchase 165,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted. (F4) These options, which were awarded on February 9, 2016, would otherwise expire and become forfeitable on February 9, 2026. |